Related Experiment Video
Updated: Feb 11, 2026
Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
Published on: November 21, 2017
Arrhythmias in Patients ≥80 Years of Age: Pathophysiology, Management, and Outcomes
Anne B Curtis1, Roshan Karki1, Alexander Hattoum1
1Department of Medicine, Jacobs School of Medicine & Biomedical Sciences, University at Buffalo, Buffalo, New York.
Insights
Older adults face unique challenges with heart arrhythmias due to aging. This review explores age-specific treatments for arrhythmias in patients 80 years and older, addressing knowledge gaps.
Area of Science:
- Cardiology
- Geriatrics
- Electrophysiology
Background:
- Increasing lifespan leads to a growing population of elderly patients (≥80 years).
- Advanced age is an independent risk factor for cardiac arrhythmias, contributing to significant morbidity and mortality.
- Elderly patients present unique challenges including cardiac remodeling, comorbidities, altered drug responses, and frailty.
Purpose of the Study:
- To review the pathophysiology of aging and its impact on cardiac arrhythmias.
- To synthesize current evidence on the age-specific management of common arrhythmias in octogenarians and older adults.
- To identify gaps in evidence for treating arrhythmias in the very elderly.
Main Methods:
- Comprehensive literature review of state-of-the-art research.
- Examination of pathophysiology linking aging and arrhythmias.
- Analysis of age-specific treatment strategies for common arrhythmias.
Main Results:
- Aging causes significant structural and electrical remodeling of cardiac tissue.
- Elderly patients exhibit distinct responses to antiarrhythmic drugs and interventions.
- Clinical trial data for very old patients with arrhythmias is notably lacking.
Conclusions:
- Effective and safe management of arrhythmias in octogenarians requires age-tailored approaches.
- Further research is crucial to address evidence gaps in treating arrhythmias in the oldest populations.
- Consideration of polypharmacy, comorbidities, and frailty is essential for treatment planning.
Abstract:
Advances in medical care have led to an increase in the number of octogenarians and even older patients, forming an important and unique patient subgroup. It is clear that advancing age is an independent risk factor for the development of most arrhythmias, causing substantial morbidity and mortality. Patients ≥80 years of age have significant structural and electrical remodeling of cardiac tissue; accrue competing comorbidities; react differently to drug therapy; and may experience falls, frailty, and cognitive impairment, presenting significant therapeutic challenges. Unfortunately, very old patients are under-represented in clinical trials, leading to critical gaps in evidence to guide effective and safe treatment of arrhythmias. In this state-of-the-art review, we examine the pathophysiology of aging and arrhythmias and then present the available evidence on age-specific management of the most common arrhythmias, including drugs, catheter ablation, and cardiac implantable electronic devices.
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
01:16ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion